A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma.
Rougier P, Adenis A, Ducreux M, de Forni M, Bonneterre J, Dembak M, Clouet P, Lebecq A, Baille P, Lefresne-Soulas F, Blanc C, Armand JP.
Rougier P, et al. Among authors: ducreux m.
Eur J Cancer. 2000 May;36(8):1016-25. doi: 10.1016/s0959-8049(00)00072-1.
Eur J Cancer. 2000.
PMID: 10885606
Clinical Trial.